What if your gene therapy research could move faster, from discovery to real clinical and market impact?

The Gene Therapy Accelerator - From Research Translation to Market-Ready Gene Therapies is a high-impact, four-week program designed to do exactly that.

Developed under the European GeneH project, this initiative supports research teams, startups, and clinical innovators in transforming promising ideas into viable therapeutic solutions - combining expert training, tailored mentoring, and direct access to a top-tier European innovation ecosystem.

Venue: IPN - Instituto Pedro Nunes, Coimbra (Portugal)

Format: Four consecutive Wednesdays (approx. 8h/week) + Demo Day

Program Highlights:

- Week 1 (22 April): Innovation pathways - from research to application
- Week 2 (29 April): Regulation, product development & funding
- Week 3 (6 May): Business strategy & entrepreneurship
- Week 4 (13 May): Pitch preparation
- Final Session: Demo Day (pitch competition)

Who should apply?

- Academic researchers
- Early-stage startups and spin-offs
- Clinical professionals and healthcare innovators

Why apply?

By joining, your team will gain the tools and guidance to:
- Translate research into real-world applications
- Build a validated business model and competitive strategy
- Develop a Regulatory & Product Roadmap for ATMPs
- Create an investor-ready pitch deck
- Connect with a multidisciplinary network of academic, clinical, industry, and policy experts

Teams: Up to 10 teams selected (max. five members per team)

Application deadline: April 3, 2026

Learn more and apply here.

This is a unique opportunity to accelerate your innovation, gain expert guidance, and position your work for real impact in the gene therapy field. We strongly encourage you to apply early - spots are limited.

We look forward to your application!
The GeneH consortium